2026-2034年全球神经内科栓塞器材市场规模、份额、趋势及成长分析报告

预计神经病学领域栓塞装置的市场规模将从 2025 年的 18.4 亿美元成长到 2034 年的 32.4 亿美元，2026 年至 2034 年的复合年增长率为 6.48%。

由于脑动脉瘤和动静脉畸形等神经系统疾病的发生率不断上升，全球神经栓塞器械市场正在不断扩大。这些疾病通常需要使用栓塞器械进行微创手术来阻塞异常血管。人们对早期诊断和治疗神经系统疾病重要性的认识不断提高，显着增加了对这些专用医疗设备的需求。

神经血管介入技术的进步是市场成长的关键。先进弹簧圈、液体栓塞剂和血流导向装置的研发提高了治疗的精确度和患者预后。此外，神经血管治疗中心的增加和微创手术的广泛应用也推动了对栓塞技术的需求。

未来几年，介入神经放射学器材的持续创新和神经系统研究投入的增加预计将对市场产生正面影响。神经系统疾病发生率的上升趋势以及新兴国家医疗基础设施的扩张也将推动市场成长。随着医疗技术的进步，栓塞手术有望变得更加安全，并得到更广泛的应用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球神经内科栓塞器材市场：依产品划分

• 市场分析、洞察与预测
• 栓塞线圈
• 液体栓塞系统
• 血流导向支架
• 动脉瘤夹
• 其他产品

第五章：全球神经内科栓塞器材市场：依治疗类型划分

• 市场分析、洞察与预测
• 缺血性中风治疗方案
• 出血性中风治疗方案

第六章：全球神经内科栓塞器材市场：依适应症划分

• 市场分析、洞察与预测
• 脑动脉瘤
• 动静脉畸形
• 其他迹象

第七章：全球神经内科栓塞器材市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他最终用户

第八章：全球神经内科栓塞器材市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Johnson & Johnson
  • Abbott Laboratories
  • Medtronic Plc
  • Heraeus Holding
  • Stryker Corporation
  • Boston Scientific Corporation
  • Kaneka Corporation
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Merit Medical Systems Inc
  • Penumbra Inc
  • Asahi Intecc Co. Ltd
  • MicroVention Inc

The Embolization Devices For Neurology Market size is expected to reach USD 3.24 Billion in 2034 from USD 1.84 Billion (2025) growing at a CAGR of 6.48% during 2026-2034.

The global embolization devices for neurology market is expanding due to the increasing prevalence of neurological disorders such as brain aneurysms and arteriovenous malformations. These conditions often require minimally invasive procedures where embolization devices are used to block abnormal blood vessels. Rising awareness about early diagnosis and treatment of neurological conditions has significantly increased the demand for these specialized medical devices.

Technological advancements in neurovascular intervention have played a key role in market growth. The development of advanced coils, liquid embolic agents, and flow-diverting devices has improved treatment precision and patient outcomes. Additionally, the growing number of neurovascular treatment centers and increased adoption of minimally invasive procedures are supporting the demand for embolization technologies.

In the coming years, the market is expected to benefit from continuous innovation in neurointerventional devices and increasing investments in neurological research. The rising burden of neurological diseases and expanding healthcare infrastructure in emerging economies are also likely to drive market expansion. As medical technology advances, embolization procedures are expected to become safer and more widely accessible.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Embolization Coils
• Liquid Embolic Systems
• Flow Diversion Stents
• Aneurysm Clips
• Other Products

By Treatment

• Ischemic Stroke Solution
• Hemorrhagic Stroke Solutions

By Indication

• Brain Aneurysms
• Arteriovenous Malformation
• Other Indications

By End User

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Johnson Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Embolization Coils Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Liquid Embolic Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Flow Diversion Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Aneurysm Clips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY TREATMENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment
• 5.2. Ischemic Stroke Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hemorrhagic Stroke Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Brain Aneurysms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Arteriovenous Malformation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Treatment
  • 8.2.3 By Indication
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Treatment
  • 8.3.3 By Indication
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Treatment
  • 8.4.3 By Indication
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Treatment
  • 8.5.3 By Indication
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Treatment
  • 8.6.3 By Indication
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson & Johnson
  • 10.2.2 Abbott Laboratories
  • 10.2.3 Medtronic Plc
  • 10.2.4 Heraeus Holding
  • 10.2.5 Stryker Corporation
  • 10.2.6 Boston Scientific Corporation
  • 10.2.7 Kaneka Corporation
  • 10.2.8 Terumo Corporation
  • 10.2.9 B. Braun Melsungen AG
  • 10.2.10 Cook Medical LLC
  • 10.2.11 Integer Holdings Corporation
  • 10.2.12 Merit Medical Systems Inc
  • 10.2.13 Penumbra Inc
  • 10.2.14 Asahi Intecc Co. Ltd
  • 10.2.15 MicroVention Inc